Potential Statistical Issues Between Designers and Regulators in Confirmatory Basket, Umbrella, and Platform Trials

Area of Science:

• Clinical trial design
• Drug development
• Regulatory science

Background:

• Platform and basket trials are innovative clinical trial designs.
• These trials aim to improve drug development efficiency across multiple disease areas.
• They present unique statistical and regulatory considerations compared to traditional trials.

Purpose of the Study:

• To highlight new statistical challenges posed by platform and basket trials.
• To discuss the regulatory implications of these advanced trial designs.
• To present a critical review of existing viewpoints on these statistical challenges.

Main Methods:

• Literature review and critical analysis of statistical methodologies.
• Examination of regulatory guidelines and challenges.
• Discussion of conflicting views on statistical issues in complex trial designs.

Main Results:

• Platform and basket trials introduce novel statistical complexities.
• Regulators face new challenges in evaluating data from these trials.
• Existing statistical approaches may require adaptation for these designs.

Conclusions:

• Addressing the statistical challenges of platform and basket trials is crucial for efficient drug development.
• Regulatory frameworks must evolve to accommodate these innovative trial designs.
• Further research and discussion are needed to refine statistical methods and regulatory oversight.